Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP658214.RAKERmhgHDKWE0P2RHDYtOaUY8OCZvnxyJOZOShdkoUdI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP658214.RAKERmhgHDKWE0P2RHDYtOaUY8OCZvnxyJOZOShdkoUdI130_assertion type Assertion NP658214.RAKERmhgHDKWE0P2RHDYtOaUY8OCZvnxyJOZOShdkoUdI130_head.
- NP658214.RAKERmhgHDKWE0P2RHDYtOaUY8OCZvnxyJOZOShdkoUdI130_assertion description "[GEP-defined high-risk designation, pertinent to 17% of patients, imparted inferior OS, EFS, and CRD in both protocols and, on multivariate analysis, was the sole adverse feature affecting OS, EFS, and CRD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658214.RAKERmhgHDKWE0P2RHDYtOaUY8OCZvnxyJOZOShdkoUdI130_provenance.
- NP658214.RAKERmhgHDKWE0P2RHDYtOaUY8OCZvnxyJOZOShdkoUdI130_assertion evidence source_evidence_literature NP658214.RAKERmhgHDKWE0P2RHDYtOaUY8OCZvnxyJOZOShdkoUdI130_provenance.
- NP658214.RAKERmhgHDKWE0P2RHDYtOaUY8OCZvnxyJOZOShdkoUdI130_assertion SIO_000772 20124509 NP658214.RAKERmhgHDKWE0P2RHDYtOaUY8OCZvnxyJOZOShdkoUdI130_provenance.
- NP658214.RAKERmhgHDKWE0P2RHDYtOaUY8OCZvnxyJOZOShdkoUdI130_assertion wasDerivedFrom befree-20140225 NP658214.RAKERmhgHDKWE0P2RHDYtOaUY8OCZvnxyJOZOShdkoUdI130_provenance.
- NP658214.RAKERmhgHDKWE0P2RHDYtOaUY8OCZvnxyJOZOShdkoUdI130_assertion wasGeneratedBy ECO_0000203 NP658214.RAKERmhgHDKWE0P2RHDYtOaUY8OCZvnxyJOZOShdkoUdI130_provenance.